Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,705 total articles
Marvell's investor day on 10/06/2026 reset expectations: FY2028 revenue guidance was raised to $20B and management disclosed an aggressive multi-year plan toward $70-90B in sales by FY2031. The stock is extended but supported by real backlog and strategic partnerships. This trade idea lays out a mid-term swing: buy into momentum with a stop below s…
Rocket Lab (RKLB) is showing improving top-line momentum, bullish technicals and a low-debt balance sheet while preparing transformational M&A and product catalysts. We outline a concrete trade: entry at $74.50, target $95.00, stop loss $64.00 over a mid-term horizon (45 trading days). The trade balances upside from launch cadence, Space Systems gr…
Energizer's combination of strong free cash flow ($150.6M), a healthy dividend yield (~5.6%), and modest leverage argues for upside from the current $21.59. We lay out an actionable long trade with precise entry, stop and target, catalysts to watch, and balanced risks.
Universal Health Realty Income Trust (UHT) yields ~8.1% and offers an income-first play with signs of stabilization: recent dividend increases, positive free cash flow of roughly $48M, and a market cap near $520M. Balance-sheet leverage and exposure to healthcare operating risk cap upside but current valuation and technicals provide a clear risk/re…
Black Stone Minerals (BSM) is showing renewed distribution growth backed by rising production and targeted acreage deals. At $14.69 the unit yields roughly 8.7% on the current quarterly payout, trades at an attractive EV/EBITDA ~10.3x, and offers a free-cash-flow yield north of 6%. That combination makes BSM a buyable name for a mid-term income tra…
Eli Lilly has built a rare position of strength in obesity and diabetes drugs, but that dominance carries valuation risk and exposure to payor pushback and competitive launches. We outline a short trade with a clear entry, stop and target and explain the fundamental and catalyst-driven path to a meaningful pullback over the next 180 trading days.
Lonza (LZAGY) looks like a buy here for investors who believe recent weakness reflects phasing and timing of capacity ramps rather than a durable hit to return on capital. The company sits in expanding CDMO and cell & gene end markets; technicals are constructive and market cap ($48.5B) already prices a mixed near-term outlook. Trade plan: enter $6…
International Seaways (INSW) is trading near $116 after a torrid move driven by record tanker spot rates. The company's balance sheet and cash generation are strong, but the market is pricing in persistent ultra-high rates. We lay out a tactical short trade: entry $116.42, stop $126.00, primary target $95.00 (mid-term), with a deeper target at $70 …
Progressive (PGR) looks like a measured long: attractive valuation, strong economics (ROE 34%), and durable distribution that benefits from AI-driven underwriting and claims automation. Enter around $212.05, stop at $200.00, target $245.00 over a 180 trading-day horizon.
BP is showing tangible signs of faster de-leveraging, portfolio high-grading and consistent earnings beats under new leadership. At $45.09 the stock is trading near the middle of its 52-week range with a 4.5% yield, light short-interest coverage and improving analyst revisions. This trade targets near-term re-rating toward previous highs while prot…
American Express has pulled back amid cyclical headwinds and investor rotation. The company’s high-margin network, affluent cardholder base, and recurring fee income make this a tactical long: enter on weakness, size for a bounce and hold for 180 trading days if fundamentals remain intact. Clear entry, stop and target are provided with risk control…
Micron's results and guidance show one thing clearly: memory is no longer a single commodity market. High-bandwidth memory and data-center SSDs tied to AI are commanding outsized revenue and margin contribution. This trade idea buys a pullback to capture continued AI-driven strength while protecting capital against cyclical price swings and aggress…
Jeronimo Martins is highly exposed to Poland via its Biedronka chain. A slowing Polish consumer, rising promotional intensity, and margin pressure create a pathway for downside over the next 45-180 trading days. This is a tactical short with defined entry, stop and target levels.
Textron mixes steady commercial aviation sales, defense programs, and industrial cash flow. At roughly $13.0B market cap, a PE near 14 and EV/EBITDA under 10 look reasonable for a business generating ~$759M in free cash flow. I recommend a tactical long with precise entry, stop and target aimed at capturing a re-rating and backlog conversion over t…
The Hartford is trading at a single-digit P/E, generates meaningful free cash flow and has a new $4.2 billion buyback authorization that should materially reduce float and support EPS. We propose a mid-term long trade to capture a valuation re-rate and buyback execution, while respecting catastrophe and underwriting risks with a defined stop.
PayPal trades at a sub-10x P/E with $6.6B in free cash flow, a $46.7B market cap and positive technicals. I lay out an actionable swing trade with entry, stop and target levels, plus the catalysts and risks that determine whether this remains a buy.
ASML’s unique position in EUV lithography, expanding manufacturing capacity and strong analyst forecasts for Q3 and FY revenues create a compelling pre-earnings trade. Valuation is rich, but the business fundamentals and technical momentum support a mid-term long into earnings with disciplined risk control.
Hormel Foods yields ~5.8% and trades close to its 52-week low after a top-line miss and lowered sales guidance. The business still throws off strong free cash flow, has limited leverage and is buying growth in foodservice with a $1.055B Brakebush deal. This trade targets income and upside recovery over 180 trading days with a defined entry, stop an…
Eli Lilly remains a growth engine thanks to GLP-1 momentum and new oncology wins, yet valuation and mixed technicals argue for a disciplined, mid-term trade. Buy on a measured entry near $1,160 with a stop under $1,110 and a target into the $1,250 area ahead of/after Q3 results.
AvePoint, a SaaS data governance specialist, stands to benefit from rising enterprise demand for agent-level AI governance. Recent research showing widespread visibility gaps plus reasonable valuation metrics and improving technicals create an actionable long trade: enter at $14.60, stop at $12.00, target $20.00 over a 180-trading-day horizon.
Intuit's shares have been punished on concerns around AI disruption, slowing customer adds and a shift toward customer-acquisition spending. That creates a tactical entry: buy near $290 for a mid-term swing to $350 over ~45 trading days, using a $260 stop. The company's $77B market cap, $8.66B in free cash flow and 30%+ growth in strategic 'Big Bet…
Rambus sits squarely in the path of AI-driven memory upgrades thanks to its high-speed memory interface IP and security offerings. The fundamentals show healthy cash generation and strong returns, yet the stock trades at a high multiple. This trade idea buys into the AI theme while protecting against execution risk with a clear stop.
Micron's fiscal momentum and capacity-backed exposure to AI data center demand argue that the recent pullback is a buying opportunity, not the end of the rally. Market-cap scale, strong free cash flow and healthy balance-sheet metrics support a tactical long. Trade with a clear stop and time-box the idea to a mid-term horizon.
Zscaler (ZS) rallied back toward $213 after a strong multi-week run, but market-capary enthusiasm and stretched multiples leave the stock vulnerable. With a market cap near $34.6B, EV/S north of 10x and negative trailing EPS, this trade targets a mid-term pullback to $170 over roughly 45 trading days using a disciplined stop at $235.
We added 1,000 shares of Enbridge (ENB) to the model portfolio at $46.88. The stock offers a 6.0% yield, stable fee-driven cash flow, and a valuation that still looks reasonable relative to cash generation. Our trade plan: entry $46.88, stop $44.00, target $54.00 over a long-term horizon (180 trading days).
